With increasing time since diagnosis, only the severe infections continued to cause symptoms.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
The Department of Health and Human (HHS) has ordered Biota Pharmaceuticals to stop research on the experimental flu antiviral drug laninamivir, the Atlanta Journal-Constitution reported yesterday.
Health officials in Anhui province reported a new H7N9 avian flu case in a 55-year-old man, according to a health department notice translated and posted yesterday by FluTrackers, an infectious disease message board.
Most flu markers in the United States declined last week, but the Northeast is still in the grip of a wave of influenza B activity, the US Centers for Disease Control and Prevention (CDC) said today in its latest FluView report.
Flu activity in Northern Hemisphere countries is headed toward interseasonal levels despite a late-season rise in influenza B activity in many areas, including Asia, the Middle East, and North America, the World Health Organization (WHO) said today in its latest global flu update. Though each flu season is different, flu experts say it's not unusual to see a late-season rise in influenza B activity.
Flu activity in the United States continued to decline last week, but some indicators were up slightly, reflecting a late-season uptick in the Northeast, according to the US Centers for Disease Control and Prevention (CDC).
China reported one new H7N9 influenza infection, in a 30-year-old man from Hunan province, according to a Chinese media report that quoted the province's health department.
The report was translated and posted by FluTrackers, an infectious disease news message board. The patient is hospitalized, and the report didn't list his condition.
China reported one additional H7N9 influenza case and another death from the virus today, according to health officials in Guangdong province.
The latest case-patient is a 79-year-old man from the Guangzhou, the province's capital, according to a health department statement translated and posted by FluTrackers, an infectious disease news message board. He is hospitalized in critical condition.
A Cochrane review that included published studies as well as unpublished drug-company data for the two most common antiviral drugs for flu—oseltamivir (Tamiflu) and zanamivir (Relenza)—found that they can shorten symptoms by about two thirds of a day but can cause side effects. The investigators also found few data to support stockpiling the drugs for pandemic or seasonal flu, according to reports today in BMJ.
China has reported two more cases of H7N9 avian flu, according to a provincial health report posted by the infectious diseases news board FluTrackers.
Both patients are from Jiangsu province, and their cases were confirmed on Apr 5. The first is a 73-year-old man from Taizhou City who is hospitalized in critical condition.
US influenza activity took a break last week from its recent pattern of steady decline, at least by some measures, the Centers for Disease Control and Prevention (CDC) reported today.
